Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
Maria Mavrikaki, PhD
Contributor
Maria Mavrikaki, PhD, studied psychology and neuroscience at the University of Crete in Greece. After obtaining her PhD, she pursued a postdoctoral research fellow position at The Scripps Research Institute in Florida, where she utilized genetic mouse models to study mechanisms underlying motivation for food. She then pursued a postdoctoral research fellowship and an assistant neuroscientist position at McLean Hospital, where she studied neurobiological mechanisms underlying prescription opioid addiction. Dr. Mavrikaki is currently staff scientist in Dr. Frank Slack’s lab at Beth Israel Deaconess Medical Center. Since March 2017, she is also an instructor in psychiatry at Harvard Medical School. Her ongoing research assesses the role of small molecules called microRNAs in opioid addiction.
Posts by Maria Mavrikaki, PhD
Addiction
Brain plasticity in drug addiction: Burden and benefit
Maria Mavrikaki, PhD
Your genes and addiction
Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
